- Home
- NBIX vs ONON Comparison
NBIX vs ONON Comparison
Compare NBIX & ONON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- ONON
- Stock Information
- Founded
- NBIX 1992
- ONON 2010
- Country
- NBIX United States
- ONON Switzerland
- Employees
- NBIX N/A
- ONON N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- ONON Shoe Manufacturing
- Sector
- NBIX Health Care
- ONON Consumer Discretionary
- Exchange
- NBIX Nasdaq
- ONON Nasdaq
- Market Cap
- NBIX 14.4B
- ONON 14.8B
- IPO Year
- NBIX 1996
- ONON 2021
- Fundamental
- Price
- NBIX $150.87
- ONON $34.99
- Analyst Decision
- NBIX Strong Buy
- ONON Strong Buy
- Analyst Count
- NBIX 18
- ONON 19
- Target Price
- NBIX $172.06
- ONON $63.68
- AVG Volume (30 Days)
- NBIX 1.0M
- ONON 6.1M
- Earning Date
- NBIX 10-28-2025
- ONON 11-12-2025
- Dividend Yield
- NBIX N/A
- ONON N/A
- EPS Growth
- NBIX 12.44
- ONON N/A
- EPS
- NBIX 4.19
- ONON 0.52
- Revenue
- NBIX $2,682,700,000.00
- ONON $3,417,915,703.00
- Revenue This Year
- NBIX $23.68
- ONON $30.53
- Revenue Next Year
- NBIX $18.02
- ONON $23.83
- P/E Ratio
- NBIX $35.78
- ONON $67.91
- Revenue Growth
- NBIX 19.61
- ONON 35.67
- 52 Week Low
- NBIX $84.23
- ONON $34.38
- 52 Week High
- NBIX $157.67
- ONON $64.05
- Technical
- Relative Strength Index (RSI)
- NBIX 59.16
- ONON 25.53
- Support Level
- NBIX $133.62
- ONON $35.35
- Resistance Level
- NBIX $157.67
- ONON $37.16
- Average True Range (ATR)
- NBIX 4.58
- ONON 1.55
- MACD
- NBIX 0.98
- ONON -0.54
- Stochastic Oscillator
- NBIX 67.98
- ONON 6.63
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About ONON On Holding AG
On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa and Asia-Pacific region.